Indication
CINV
1 clinical trial
1 product
1 drug
Clinical trial
A Phase III Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer Receiving 5-day Cisplatin Combination ChemotherapyStatus: Recruiting, Estimated PCD: 2023-12-31
Product
OlanzapineDrug
Varlilumab